New Look at Immune Cells in Type 1 Diabetes: What Scientists Found in the Pancreas

Type 1 diabetes develops when the immune system mistakenly attacks the beta cells in the pancreas that produce insulin. CD8+ T cells—a type of white blood cell—are known to play a central role in this attack. However, scientists have had incomplete understanding of exactly what goes wrong with these cells and why they turn against the body.

A new study published in The Journal of Clinical Investigation examined immune cells in pancreatic lymph nodes—small immune organs near the pancreas—from people with type 1 diabetes. Using advanced technologies to profile thousands of individual cells, researchers discovered patterns that suggest the immune system's regulation has broken down in specific ways.

The researchers found that CD8+ T cells in type 1 diabetes pancreatic lymph nodes have an unexpected combination of characteristics. These cells display markers of stem cell-like memory T cells—which are typically long-lived and capable of launching robust immune responses. At the same time, they show reduced expression of genes associated with cellular exhaustion, which normally act as a brake on immune cells.

This pattern is unusual because it suggests these cells are in a state of heightened readiness rather than being naturally kept in check. The cells also expressed elevated levels of inflammatory signaling molecules, indicating they are primed to mount an attack.

When researchers analyzed which molecular pathways were active in these abnormal CD8+ cells, one signaling system stood out: IL-15. This is a chemical messenger that helps direct immune cell development and activation. The prominence of IL-15 signaling suggests it may be a key factor in driving the immune dysregulation seen in type 1 diabetes.

This finding could be important because IL-15 represents a potential point where interventions might work to restore immune balance, though much additional research would be needed to test this idea.

The study revealed that aggressive CD8+ T cells found in pancreatic lymph nodes are the same cells that migrate into the pancreas tissue itself. Once in the pancreas, these cells display even stronger signatures of terminal effector function—meaning they are positioned and primed to directly attack target cells.

Interestingly, within the pancreas, researchers found a mixture of activation and exhaustion markers on certain populations of T cells near the islets—the clusters of cells containing insulin-producing beta cells. This suggests the immune attack involves complex, competing signals within the tissue itself.

By mapping the molecular profiles of immune cells in type 1 diabetes tissues, this research provides a detailed picture of what immune dysregulation looks like at the cellular level. These findings create a foundation for identifying new therapeutic targets—specific molecules or pathways that could be modified to restore immune balance.

The study does not provide immediate treatment recommendations, but it does clarify which cellular players and signaling systems are central to disease development. This kind of precise understanding is essential for designing future therapies that might prevent or delay the onset of type 1 diabetes.

Source: The Journal of clinical investigation. Evidence type: PubMed indexed literature. Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.